www.fdanews.com/articles/183370-adherium-receives-fda-510k-clearance-for-next-generation-smartinhaler
![FDA_Logo_Black_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Black_2016.gif?t=1579040596&width=430)
Adherium Receives FDA 510(k) Clearance for Next Generation Smartinhaler
September 6, 2017
The FDA cleared Adherium’s SmartTouch inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.
The device is installed onto a patient’s inhaler to monitor and encourage medication adherence as part of a self-management plan.
The device records the date and time the inhaler is used and automatically transmits the information to an app on the patient’s phone or tablet.